| Literature DB >> 33602872 |
Andrew J Innes1,2,3, Bin Sun1,2, Verena Wagner1,2, Sharon Brookes1,2, Domhnall McHugh1,2, Joaquim Pombo1,2, Rosa María Porreca1,2, Gopuraja Dharmalingam1,2, Santiago Vernia1,2, Johannes Zuber4, Jean-Baptiste Vannier1,2, Ramón García-Escudero5,6,7, Jesús Gil1,2.
Abstract
Senescence is a key barrier to neoplastic transformation. To identify senescence regulators relevant to cancer, we screened a genome-wide shRNA library. Here, we describe exportin 7 (XPO7) as a novel regulator of senescence and validate its function in telomere-induced, replicative, and oncogene-induced senescence (OIS). XPO7 is a bidirectional transporter that regulates the nuclear-cytoplasmic shuttling of a broad range of substrates. Depletion of XPO7 results in reduced levels of TCF3 and an impaired induction of the cyclin-dependent kinase inhibitor p21CIP1 during OIS. Deletion of XPO7 correlates with poorer overall survival in several cancer types. Moreover, depletion of XPO7 alleviated OIS and increased tumor formation in a mouse model of liver cancer. Our results suggest that XPO7 is a novel tumor suppressor that regulates p21CIP1 expression to control senescence and tumorigenesis.Entities:
Keywords: TCF3; XPO7; functional screen; p21CIP1; senescence; tumor suppressor
Year: 2021 PMID: 33602872 PMCID: PMC7919420 DOI: 10.1101/gad.343269.120
Source DB: PubMed Journal: Genes Dev ISSN: 0890-9369 Impact factor: 11.361